MedPath

A comparative study of lesser dose of carbetocin versus regular dose of carbetocin in the prevention of bleeding during planned cesarean delivery

Not Applicable
Completed
Conditions
Health Condition 1: O721- Other immediate postpartum hemorrhage
Registration Number
CTRI/2022/03/041222
Lead Sponsor
Dr Rajasri G Yaliwal
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
216
Inclusion Criteria

Consenting Term pregnancy(37-42 weeks of gestation) undergoing elective LSCS under subarachanoid block (Spinal Anesthesia)

Exclusion Criteria

1.Women in labour

2. Women having Coagulopathies

3. Women with Hypertensive disorder

4. Women with cardiaovascular disorders, hepatic and renal diseases

5. Women with Epilepsy

6. Women having known conditions predisposing to atonic PPH like hydramnios, Multiple gestation prolonged labor.

7. Women requiring General Anaesthesia

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Assessment of blood loss: Change in the pre and post hemoglobin levels and hematocritTimepoint: 72 hours after the operation
Secondary Outcome Measures
NameTimeMethod
cardoivasular changes and tone of the uterusTimepoint: 1 min <br/ ><br>5min <br/ ><br>10min <br/ ><br>15min <br/ ><br>1hour
© Copyright 2025. All Rights Reserved by MedPath